Abstract
Small heat shock proteins (sHSPs) belong to a family of 12- to 43-kDaproteins that are ubiquitous and are largely conserved in amino acid sequence among allorganisms. The principal heat-shock proteins that have chaperone activity (that is, they protectnewly made proteins from misfolding) belong to five conserved classes HSP100,HSP90, HSP70, HSP60 and the small heat-shock proteins (sHSPs). The sHSPs (which include alpha crystallin) can form large multimeric structures and have a wide range of cellular functions,including endowing cells with thermotolerance in vivo and being able to act as molecular chaperones in vitro sHSPs do this by forming stable complexes with folding -or unfolding- intermediates of their proteinsubstrates, probably the molten globule. This paper includes a brief survey of the chaperone family, the small heat shock protein superfamily,transcription of sHSPs, sequence comparisons and structural models of small heat shock proteins - structuralelements as potential drug targets, sHSPs as chaperone-like proteins, alpha crystallin chaperone-like activity,conformational diseases - the role of alpha crystallin small heat shock protein superfamily proteins, post-translationalmodification and useful pharmacological agents. Functionality of small heat shock proteins - targets and diseases where pharmacologically active agents are ofimportance, alpha crystallin- small heat shock proteins and prion diseases specific targets for diagnostic testsand drug development, details of some specific small heat shock proteins as drug targets, structural andfunctional implications for treatment.
Keywords: chaperone activity, Small Heat Shock Proteins, Drug Targets, HSP90, HSP70, HSP60, HSP100, Molecular Chaperones, Chaperone-like-protein, GroEL
Current Pharmaceutical Biotechnology
Title: Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Volume: 2 Issue: 1
Author(s): M. James C. Crabbe and Henry W. Hepburne-Scott
Affiliation:
Keywords: chaperone activity, Small Heat Shock Proteins, Drug Targets, HSP90, HSP70, HSP60, HSP100, Molecular Chaperones, Chaperone-like-protein, GroEL
Abstract: Small heat shock proteins (sHSPs) belong to a family of 12- to 43-kDaproteins that are ubiquitous and are largely conserved in amino acid sequence among allorganisms. The principal heat-shock proteins that have chaperone activity (that is, they protectnewly made proteins from misfolding) belong to five conserved classes HSP100,HSP90, HSP70, HSP60 and the small heat-shock proteins (sHSPs). The sHSPs (which include alpha crystallin) can form large multimeric structures and have a wide range of cellular functions,including endowing cells with thermotolerance in vivo and being able to act as molecular chaperones in vitro sHSPs do this by forming stable complexes with folding -or unfolding- intermediates of their proteinsubstrates, probably the molten globule. This paper includes a brief survey of the chaperone family, the small heat shock protein superfamily,transcription of sHSPs, sequence comparisons and structural models of small heat shock proteins - structuralelements as potential drug targets, sHSPs as chaperone-like proteins, alpha crystallin chaperone-like activity,conformational diseases - the role of alpha crystallin small heat shock protein superfamily proteins, post-translationalmodification and useful pharmacological agents. Functionality of small heat shock proteins - targets and diseases where pharmacologically active agents are ofimportance, alpha crystallin- small heat shock proteins and prion diseases specific targets for diagnostic testsand drug development, details of some specific small heat shock proteins as drug targets, structural andfunctional implications for treatment.
Export Options
About this article
Cite this article as:
Crabbe James C. M. and Hepburne-Scott W. Henry, Small Heat Shock Proteins (sHSPs) As Potential Drug Targets, Current Pharmaceutical Biotechnology 2001; 2 (1) . https://dx.doi.org/10.2174/1389201013378833
DOI https://dx.doi.org/10.2174/1389201013378833 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics.
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
Machine Learning and Artificial Intelligence for Medical Data Analysis and Human Information Analysis in Healthcare
The intersection of machine learning (ML) and artificial intelligence (AI) with the pharmaceutical industry is revolutionizing traditional paradigms in drug discovery and development. These technologies have introduced innovative approaches to analyzing complex datasets and predicting chemical properties, leading to more efficient identification and optimization of drug candidates. By employing sophisticated ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Current Drug Delivery Nerve Growth Factor Receptors and Signaling in Breast Cancer
Current Cancer Drug Targets Effect of Prostaglandins on the Regulation of Tumor Growth
Current Medicinal Chemistry - Anti-Cancer Agents The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer’s and Other Neurological Diseases
Current Pharmaceutical Design Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Current Medicinal Chemistry Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Clinical Relevance of Alternative Lengthening of Telomeres in Cancer
Current Topics in Medicinal Chemistry Targeting Epigenetic Modifiers: Promising Strategies for Cancer Therapy and Beyond
Current Drug Therapy New Trends of Deep Learning in Clinical Cardiology
Current Bioinformatics Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
Current Medicinal Chemistry Novel Insights into Targeting ATP-Binding Cassette Transporters for Antitumor Therapy
Current Medicinal Chemistry The Anti-cancer Actions of Vitamin D
Anti-Cancer Agents in Medicinal Chemistry “Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development
Current Medicinal Chemistry Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET
Current Medicinal Chemistry Molecular Mechanisms Underlying the Functions of Cellular Markers Associated with the Phenotype of Cancer Stem Cells
Current Stem Cell Research & Therapy Id-1B, an Alternatively Spliced Isoform of the Inhibitor of Differentiation-1, Impairs Cancer Cell Malignancy Through Inhibition of Proliferation and Angiogenesis
Current Molecular Medicine Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal